Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PQ loop repeat-containing protein 2 (PQLC2), also known as SLC66A1, is a specialized lysosomal membrane transporter responsible for the export of basic amino acids—specifically L-arginine, L-lysine, and L-histidine—from the lysosomal lumen into the cytosol [1, 2]. It plays a pivotal role in maintaining cellular amino acid homeostasis and nutrient recycling following the degradation of proteins within the lysosome [2]. Beyond its basic physiological role, PQLC2 is a critical component of the therapeutic mechanism for cystinosis; it provides an alternative exit route for cystine when converted by the drug cysteamine into a lysine-mimetic mixed disulfide [3]. In oncology, PQLC2 is increasingly recognized as a potential target because cancer cells often rely on lysosomal nutrient scavenging and PQLC2-mediated arginine export to sustain growth and activate the mTORC1 pathway under nutrient-deprived conditions [2, 3]. Consequently, modulating PQLC2 activity offers a strategic pathway for treating metabolic disorders and inhibiting tumor progression by disrupting essential nutrient signaling [1]. Sources: [1] UniProt Consortium. UniProtKB - Q96LJ7 (PQLC2_HUMAN). [2] Liu, B., et al. (2012). LAAT-1 is the lysosomal lysine/arginine transporter that maintains amino acid homeostasis. Science. [3] Jézégou, A., et al. (2012). Heptahelical protein PQLC2 is a lysosomal arginine exporter underlying the action of cysteamine in cystinosis. Proceedings of the National Academy of Sciences (PNAS).
PQLC2 acts as a pH-dependent exporter of basic amino acids (arginine, lysine, and histidine) from the lysosomal lumen to the cytosol. In the treatment of cystinosis, it facilitates the export of the cysteamine-cysteine mixed disulfide, which structurally mimics lysine, thereby bypassing the defective cystinosin transporter.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PQ loop repeat-containing protein 2 (PQLC2).